Ello, Domingo .
HRN: 06-35-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/15/2024
04/22/2024
IVT
500 Mg
Q8h
Cholelithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes